-
Innovation Ranking
Innovation Ranking – Nien Made Enterprise Co., Ltd.
Nien Made Enterprise Co Ltd (Nien Made) is a manufacturer and distributor of custom curtains. The company offers products such as Shutters, Cellular Shades, Blinds, Roller Shades, Roman Shades, and BelleVue Shades. Nien Made offers blinds and wood shutters under the brand names NORMAN and VENETA. It also designs, manufactures, and sells automated appliances and PVC tubes. In addition, it also engages in manufacturing and selling dehumidifiers and air purifiers; the provision of logistics support services and window coverings documentation...
-
Sector Analysis
NewUnited Kingdom (UK) Home Window Dressings Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Window dressings 2024 report offers a comprehensive insight into consumer attitudes in the UK window dressings market. The report focuses on seven key subcategories: readymade curtains, made to measure curtains, readymade blinds, made to measure blinds, shutters, nets and voiles, and window dressing accessories. Consumer data is based on our 2024 UK window dressings survey, using a panel of 2,000 nationally representative consumers.
-
Company Insights
NewKlarna – Competitor Profile
Klarna is a Swedish online payment services provider (PSP) that offers a range of buy now pay later (BNPL) solutions. Established in 2005, the company now serves over 150 million customers and is accepted by over 550,000 merchants across 45 countries. Klarna acquired SOFORT in 2014 and BillPay in 2017, turning it into one of the largest PSPs in the European ecommerce space. Klarna offers both immediate and pay-later options for ecommerce purchases, allowing customers to make payments after receiving...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRX-100 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRX-100 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRX-100 in Melanoma Drug Details: CRX-100 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRX-100 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRX-100 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRX-100 in Non-Small Cell Lung Cancer Drug Details: CRX-100...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Alpha Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Beta Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Beta Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Company Insights
NewAlipay – Competitor Profile
Launched in 2004, Alipay is among the leading alternative payment services providers (PSP) globally. It is a subsidiary of Ant Group, which is controlled by Alibaba Group. Alipay allows users to make fund transfers as well as online, in-app, and in-store payments at home and abroad. It is the primary method of payment for Alibaba’s online marketplaces, including AliExpress, Tmall, and Taobao. Alipay is accepted in more than 110 countries, allowing Chinese tourists to make payments in Chinese renminbi and...
-
Thematic Analysis
NewCybersecurity in Banking and Payments – Thematic Intelligence
Cybersecurity in Banking and Payments Thematic Report Overview The rapid evolution of digital banking and the growing number of interconnected devices have made it easier for customers to manage their finances through online channels. Unfortunately, this has exposed banking companies to increasing levels of cyber threats. Since the impact of cyberattacks on banks can be catastrophic, stronger measures will be needed to counter the continuously evolving cyber threat landscape. Due to the proliferation of data breaches and digital heists across...
-
Thematic Analysis
NewCloud Services Sector Scorecard, Q1 2024 Update – Thematic Intelligence
The thematic screen of GlobalData’s cloud services sector scorecard is led by the global hyperscalers Microsoft and Amazon, with Alphabet and IBM also in the top 10. Microsoft and Alphabet, in particular, are aggressively investing in generative artificial intelligence (AI), developing foundational large language models (LLM), and building the infrastructure to offer related services to customers. In recent months, Alphabet launched its Gemini AI model, Microsoft launched its own AI chips and also invested in Mistral, and Microsoft’s strategic partner...